Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy. - Wikidata - awgldk - TriplyDB

Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.

Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.

http://www.wikidata.org/entity/Q41115090

about

Review of vancomycin-induced renal toxicity: an update Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.Optimizing Guideline-Recommended Antibiotic Doses for Pediatric Infective Endocarditis.Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.Increasing evidence of the nephrotoxicity of piperacillin/tazobactam and vancomycin combination therapy - what is the clinician to do?MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI.Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.Evaluation of the Risk for Acute Kidney Injury in Adult Cystic Fibrosis Patients Receiving Concomitant Vancomycin and Tobramycin.Characterization of the Clinical Outcomes With Cefepime in a Neonatal Intensive Care Unit: A Retrospective Cohort Study.

P2860

Q26746932-3E39F70E-3C4A-41DA-A806-EA031FF263CC Q38641774-6D98839F-885F-45BA-9F91-48308B9E90F0 Q38903089-14F40478-F8F4-4D5F-9DCA-034FFBEC8F6F Q40048536-B35F4A5E-0BCB-4E94-969F-DC1F5590EFF7 Q41987133-E98CACBE-136B-40F3-83AF-FE7EF8B7B9C9 Q47164367-4D76439B-47FE-4DF9-9B6F-940EAFF300D7 Q48234771-B47E05E2-79D4-4EA2-BC1F-1290F54DE43C Q53636658-71CA7473-A49F-49A1-BF84-0E62EA6A89B8 Q54995486-0DA1FED7-B260-41F3-AA96-AE0B213A63DD Q55404164-05D535C0-DE44-48F0-B3CF-D9770817FEC9

P2860

Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.

http://www.wikidata.org/entity/Q41115090

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Late-Occurring Vancomycin-Asso ...... n Receiving Prolonged Therapy.

@en

type

label

Late-Occurring Vancomycin-Asso ...... n Receiving Prolonged Therapy.

@en

prefLabel

Late-Occurring Vancomycin-Asso ...... n Receiving Prolonged Therapy.

@en

P1433

Q41115090-72222E76-236B-430F-B121-6AC2135A3D86

P1476

Q41115090-B3A60C3D-942E-40C6-9300-CB8276721259

P2093

Q41115090-554EE5DB-EF1D-486E-BD42-04C294C809F8

Q41115090-A1C8C851-9359-4FE2-AB62-699BD52A1CB1

Q41115090-A24A0D7F-E638-4B07-AAAB-E0F75F61A12A

Q41115090-BB2A69F0-5B97-4BDA-8176-D2577B6219E9

P2860

Q41115090-0E9F70FE-3844-4BC3-BA3B-F8F40E42653B

Q41115090-1E1BC545-A3A0-4227-9CC9-A7002B8D69B7

Q41115090-59DF51AD-FD8D-4A4C-A3B5-51738F040539

Q41115090-63ABD0F2-4BA4-4A9B-9209-6540AE5D32F9

Q41115090-67FE4381-50DC-4434-9B2F-269E251FA31D

Q41115090-6896F7B9-5530-45A7-8F45-3D30259F8BFD

Q41115090-6B1E0CED-73AD-4BF1-9165-58F3367E6369

Q41115090-70E8AC2D-5757-4774-8F26-4DDB7EA58376

Q41115090-7A69DDAB-D414-4AC0-8983-2BCC93559BEE

Q41115090-8A4681A5-929F-4DCF-B5FD-1B8FB05BA537

P304

Q41115090-A2D80258-BD21-41C3-BD9E-792A43C73EF4

P31

Q41115090-B35DA4EE-3E98-4592-B020-E010B540F639

P356

Q41115090-0AEE02B3-3345-42DA-A10F-A470DD7AA98B

P407

Q41115090-72A5176C-DD99-4962-8A8E-C42088A4FC77

P433

Q41115090-222A7F7A-0AA1-46B2-A7F8-B3A1E170AC0E

P478

Q41115090-CFA4D262-55E3-43F9-9C69-24DF8DF8F00D

P577

Q41115090-C8DBE21C-99FF-4808-A2E4-783DB3A92D51

P698

Q41115090-EF5086BA-81D3-446B-B859-51A8A4EA11ED

P356

1060028015594190

P1433

Annals of Pharmacotherapy

P1476

Late-Occurring Vancomycin-Asso ...... n Receiving Prolonged Therapy.

@en

P2093

Allison L Gritzman

http://www.w3.org/2001/XMLSchema#string

Amy C Wilson

http://www.w3.org/2001/XMLSchema#string

Chad A Knoderer

http://www.w3.org/2001/XMLSchema#string

Kristen R Nichols

http://www.w3.org/2001/XMLSchema#string

P2860

Nephrotoxicity as a cause of acute kidney injury in children.

Vancomycin monitoring in children using bayesian estimation.

Modified RIFLE criteria in critically ill children with acute kidney injury.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.

Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.

Improved vancomycin dosing in children using area under the curve exposure.

Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.

Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study.

Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.

P304

1113-1119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028015594190

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26160972

http://www.w3.org/2001/XMLSchema#string